s6y
Company name or ticker
Search
Telomir Pharmaceuticals, Inc.
8-K
Current report filing
Filed
Thursday, April 30, 2026
Period
Apr 24, 2026
Accession number
0001493152-26-019773
Documents
8-K
8-K
XBRL SCHEMA FILE
EX-101.SCH
XBRL LABEL FILE
EX-101.LAB
XBRL PRESENTATION FILE
EX-101.PRE
On sec.gov
Filing index
All files
Complete submission text
SGML header